Explore UAB

Gastroenterology & Hepatology

Forging the future of gastroenterology and hepatology

The UAB Division of Gastroenterology and Hepatology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most advanced care.

OUR PROGRAMS

Preparing the next generation of physicians and scientists

We're dedicated to nurturing and guiding the future generation of physicians and physician-scientists, recognizing that our trainees are the cornerstone of our nation's healthcare system.

OUR PEOPLE

Home to leading experts and distinguished scholars

Our faculty, staff, and trainees play an exceptionally critical role in shaping the future of healthcare through their expertise in education, research, and clinical practice, driving innovation and excellence.

Latest Headlines

  • UAB receives renewed funding for colorectal cancer screening project
    Nov 18, 2024
  • UAB celebrates milestone with 3,000 adult liver transplants
    Sep 26, 2024
  • UAB Hospital continues to be the best hospital in Alabama, Birmingham metro, according to U.S. News & World Report
    Jul 16, 2024
  • UAB to offer free colonoscopy screenings to under- and uninsured for second consecutive year
    May 21, 2024


Professor of Genetics
Phone: 205-934-2288
E-Mail: trs@uab.edu

schoeb

Dr. Schoeb received his B.S. in pre-veterinary sciences and D.V.M. from  Oklahoma State University. He then did a residency in veterinary pathology and earned a M.S. in veterinary pathology. He entered the UAB graduate program in Molecular and Cellular Pathology sponsored by the Departments of Comparative Medicine and Pathology, earning a Ph.D. in pathology.  Dr. Schoeb joined the UAB Department of Genomics and Pathobiology in 2000.  He is currently in the Department of Genetics (Genomics Division) and Associate Director of the Comparative Pathology Laboratory in the UAB Animal Resources Program.

Dr. Schoeb’s research focuses on gnotobiotic and specific pathogen-free (SPF) rodents and the phenotyping of mutant mice. He has participated in a wide variety of projects involving evaluation of disease expression in rodents and other species. His current interests are in development of gnotobiotic mouse models of inflammatory bowel disease and identification of specific intestinal bacteria involved in initiation and/or perpetuation of intestinal inflammation in these models.

Selected Publications

  1. McGinn, T.M., Tao, B., Cartner, S., Schoeb, T., Davis, I., Ratner, L. and Fultz, P.N. Association of primate T-cell lymphotropic virus infection of pig-tailed macaques with high mortality. Virology 304:364-378, 2002.
  2. Flanagan, E.B., Schoeb, T.R. and Wertz, G.W. Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice. J. Virol. 77:5740-5748, 2003.
  3. Barlow, S.C., Collins, R.G., Ball, N.J., Weaver, C.T., Schoeb, T.R. and Bullard, D.C. Psoriasiform dermatitis susceptibility in Itgb2tm1Bay PL/J mice requires low level CD18 expression and at least two additional loci for progression to severe disease. Am. J. Pathol. 163:197-202, 2003.
  4. Goetzman, E.S., Tian, L., Nagy, T.R., Gower, B.A., Schoeb, T.R., Elgavish, A., Acosta, E.P., Saag, M.S. and Wood, P.A. HIV protease inhibitor ritonavir induces lipoatrophy in male mice. AIDS Res. Hum. Retroviruses 19:1141-1150, 2003.
  5. Barlow, S.C., Xu, H., Weaver, C.T., Lindsey, J.R., Schoeb, T.R. and Bullard, D.C. Development of dermatitis in CD18-deficient PL/J mice is not dependent on bacterial flora, and requires both CD4+ and CD8+ T lymphocytes. Int. Immunol. 16:345-351, 2004.
  6. Pastva, A,, Estell, K., Schoeb, T.R., Atkinson, T.P. and Schwiebert, L.M. Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma. J.Immunol. 172:4520-4526, 2004.
  7. Woolard, M.D., Hodge, L.M., Jones, H.P., Schoeb, T.R. and Simecka, J.W. The upper and lower respiratory tracts differ in their requirement of IFN-gamma and IL-4 in controlling respiratory mycoplasma infection and disease. J. Immunol. 172:6875-6883, 2004.
  8. Kevil, C.G., Hicks, M.J., He, X., Zhang, J., Ballantyne, C.M., Raman, C., Schoeb, T.R. and Bullard, D.C. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Faslpr mice from autoimmune disease. Am.J. Pathol. 165:609-616, 2004.
  9. Tu, A.-H., Clapper. B., Schoeb, T.R., Elgavish, A., Zhang, J., Liu, L., Yu, H. and Dybvig, K. Association of a major protein antigen of Mycoplasma arthritidis with virulence. Infect. Immun. 73:245-249, 2005.
  10. Mrug, M., Li, R., Cui, X., Schoeb, T.R., Churchill, G.A. and Guay-Woodford, L.M. Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. J. Am. Soc. Nephrol.16:905-916, 2005.